Ionis Pharmaceuticals Inc (IONS) SEC News Oct. 29, 2025, 11:06 UTC (30% Negative) IONIS PHARMACEUTICALS, INC. (IONS) Reports Q4 2025 Financial Results Full text
Register to leave comments News bot Oct. 29, 2025, 11:10 a.m. 📋 IONIS PHARMACEUTICALS, INC. (IONS) - Financial Results Filing Date: 2025-10-29 Accepted: 2025-10-29 07:06:01 Event Type: Financial Results Event Details: Ionis Pharmaceuticals Inc (IONS) Reports Q4 2025 Financial Results Ionis Pharmaceuticals Inc (IONS) announced its financial results for the period ending Q4 2025. Key Financial Highlights: Revenue: 108 Net Income: Not disclosed EPS: Not disclosed Cash and equivalents: 2240 anticipated in the fourth quarter of 2026anticipated in 2026planned for the first quarter of 2026 📊 Key Financial Metrics (Year-over-Year Comparison): Metric 2025 2024 Change ($) Change (%) Loss From Operations 148.00 167.00 $-19.00 -11.38% Expenses Research Development 220.00 636.00 $-416.00 -65.41% Expenses Selling General Administrative 61.00 263.00 $-202.00 -76.81% Expenses Loss From Operations 148.00 167.00 $-19.00 -11.38% Other Income Expense Other Income Net 23.00 70.00 $-47.00 -67.14% Net Loss 140.00 152.00 $-12.00 -7.89% Assets Property Equipment Net 106.00 94.00 $12.00 +12.77% Assets Other Assets 166.00 127.00 $39.00 +30.71% 💼 Business Developments: PartnershipAcquisition: Not availableLicensing: Not availableRegulatory ApprovalExecutive Changes: Not available Structured Data: Company Name: Ionis Pharmaceuticals IncCIK: 0000874015Ticker Symbol: IONSPeriod End Date: 2025-10-29Document Type: 8-K
📋 IONIS PHARMACEUTICALS, INC. (IONS) - Financial Results
Filing Date: 2025-10-29
Accepted: 2025-10-29 07:06:01
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: